RAC 4.00% $1.44 race oncology ltd

Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,006 Posts.
    lightbulb Created with Sketch. 3672
    There's been a lot of complaining about clinical delays of late. These delays were apparent 18 months ago.

    The strategy released in March 2022 aimed to develop the cardioprotection and FTO opportunities to POC and then transact.
    https://hotcopper.com.au/data/attachments/5612/5612191-a02fd507c10f52a3e90c45adc8ea79fb.jpg
    This is still achievable.

    Multiple value inflection points along the way - i.e. the potential for Sheba 2.0 data (imminent) to result in the license of AML/RC110 as an example. The notion that the company will be unable to deliver upside to shareholders until a transaction occurs is a false narrative.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.44
Change
-0.060(4.00%)
Mkt cap ! $245.4M
Open High Low Value Volume
$1.50 $1.50 $1.44 $57.11K 38.73K

Buyers (Bids)

No. Vol. Price($)
2 2499 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.46 247 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.